Michael SinhaMichael S. Sinha
Dartmouth College, BA 2003
Southern Illinois University School of Medicine, MD 2012
Southern Illinois University School of Law, JD 2012
Harvard T.H. Chan School of Public Health, MPH 2015

Office: 202 Knowles Center
Mail: 416 Huntington Avenue, Boston MA 02115
Tel: (617) 373-5149
E-mail: m.sinha@northeastern.edu

Dr. Michael Sinha is a Regulatory Science Fellow in the new Harvard-MIT Center for Regulatory Science, within the Harvard Program in Therapeutic Science (HiTS) at Harvard Medical School. He is also affiliated with the Program On Regulation, Therapeutics, And Law (PORTAL), within the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine at Brigham and Women’s Hospital. His legal scholarship includes articles in the American Journal of Legal Medicine, the American Journal of Law and Medicine, the Journal of Law, Medicine & Ethics, the Harvard Law & Policy Review, the Food & Drug Law Journal, the Stanford Law & Policy Review and the Hastings Law Journal (forthcoming). Medical publications have appeared in JAMAJAMA Internal MedicineCHESTPLOS Medicine, the American Journal of BioethicsDrug Safety, Mayo Clinic Proceedings (forthcoming), and the Health Affairs Blog. Research interests include FDA and pharmaceutical law, intellectual property law and antitrust law. Dr. Sinha has co-authored two articles with Professor Wendy Parmet, faculty director of the Center for Health Policy and Law,, related to panic and emerging infectious diseases: “The Perils of Panic: Ebola, HIV, and the Intersection of Global Health and Law,” 42 American Journal of Law and Medicine 223 (2016) and “A Panic Foretold: Ebola in the United States,” Critical Public Health (2016).

Fields of Expertise: 
FDA and Pharmaceutical Law
Intellectual Property Law
Antitrust Law